Interferon-gamma (IFN-␥) is a key regulator of the development and functions
Introduction
Interferons are a small group of cytokines that include alpha, beta and gamma interferons (IFN-␣, ␤, ␥). IFN-␥ is a pleiotropic cytokine that is a key regulator of the development and functions of the immune system. The principal sources of IFN-␥ are helper T cells and natural killer cells, although many other cells can produce it. The human IFN-␥ gene, consists of four exons and is located near D12S335 and D12S313 microsatellites on 12q15.
1,2 It encodes a polypeptide of 166 amino acids with a 20-amino acid signal peptide.
Deletion analysis studies have defined the core IFN-␥ promoter 3, 4 which covers the −100 to −30 region and is much conserved through evolution. Furthermore enhancer sites have been located in the first intron and several NFB binding sites have been described in introns 1, 2 and 3. 5, 6 Genomic DNA constructs lacking most intronic sequences have consistently exhibited a decrease of transcription activity. It is not clear, however, whether NFB/NFAT complexes have positive or negative effects on transcription. These complexes interact with CD28 and CD28 responsive elements in the promoter and in the third intron. These data indicate that several transcription regulatory regions are distributed along the gene. We have searched for polymorphisms in the IFN-␥ gene because of its important role in regulating inflammation and fibrosis in human schistosome infection. We describe here three new polymorphisms in the intronic and 3′UTR regions of the IFN-␥ gene.
Results and discussion
We searched for IFN-␥ polymorphisms in SUDANESE subjects from a region of endemic schistosomiasis. We sought single-strand conformational polymorphisms (SSCP) with sets of primers covering the full gene (see primers in Table 1 ). Polymerase chain reaction (PCR) products were electrophoresed at 4°C and at room temperature. PCR products obtained from the DNA of patient 27 amplified with the 10a/b primers exhibited an additional band on SSCP gel compared to the products obtained from DNA of patient 33 (Figure 1a) . Two other polymorphisms were detected using the 16a/b and 21a/b primer sets: PCR products obtained from the DNA of patient 38 and 26 with primers 16a/b and 21a/b respectively exhibited SSCP patterns different from other subjects (subjects 18 and 6 respectively) (Figures 2a and 3a) . Polymerase chain reactions were carried out on a robocycler gradient 96 (Stratagene, La Jolla, CA, USA) in 30-l reactions containing 1 M of each primer 100 ng DNA, 10 mM Tris-HCl pH = 9, 0.1% Triton X-100, 50 mM KCl, 0.2 mg/ml BSA, 1.5 mM MgCl 2 , 1 mM of dNTP and 1.5 U Taq polymerase (Appligene, Illkirsch, F). Following the initial denaturation step (94°C, 5 min) the samples were subjected to 35 cycles consisting of 94°C for 1 min, annealing temperature for 45 s and 72°C for 45 s Figure 1 Analysis of the point mutation at position +2109. This polymorphism detection analysis was performed on subjects of a SUDANESE village of Arabic origin (Meisseria and Rawashda tribes). Venous blood was collected and DNA extractions were performed using the standard salting out method. (a) Analysis of PCR products by SSCP. 9 20 l of PCR reaction products were added to 20 l of 0.2N NaOH solution and denatured (95°C for 5 min). 20 l of loading buffer were added to the denatured products prior to electrophoresis on MDE gel (×0.5) in TBE ×1 at 7 mA (constant amperage) for 16 h at room temperature. Gel were stained for 10 min in ethidium bromide solution (1 g/ml). (b) Purified PCR reaction products were sequenced using ABI Prism BigDye Terminator cycle sequencing system (PE Applied Biosystems, Foster City, CA, USA) on an ABI Prism 310 automatic sequencer. Sequencing reactions were performed on both strands. (c) The PCR reaction products obtained from subjects 27 and 33 were sequenced with primers 10a and 10b. Chromatograms confirmed the heterozygous status of subject 27. Sequences obtained from subjects 27 and 33 have been deposited in GenBank (numbers: AF408170 and AF408171 respectively). Sequence alignment located the mutation at position +2109 from the transcription start using the J00219 sequence as reference.
(G/G) whereas subject 38 was heterozygous (G/A). Finally a transition G to A was identified at position +5134 in the 3′UTR region (Figure 3b and 3c) . Subject 6 was heterozygous (G/G) whereas subject 26 was heterozygous (G/A).
The transition +2109 (A to G) creates an AciI restriction site. Restriction site analysis of PCR products from patients 27 and 33 obtained with 10a/b confirmed this polymorphism. Subject 33 PCR products were not digested (one 365-bp band) whereas subject 27 PCR products were partially digested as three fragments are visible on gel (106-bp, 259-bp and 365-bp fragments) (Figure 4) .
The frequency of each polymorphism were determined in the population from which originate the subjects studied above. Out of 134 subjects, 95 and 39 individuals presented the +2109A/A and +2109A/G genotype respectively. Allelic frequencies were 85% (+2109A) and 15% (+2109G). Out of 99 subjects, 84 and 15 individuals had the +3810G/G and +3810G/A genotype respectively. Allelic frequencies were 92% (+3810G) and 8% (+3810A). Finally, out of 78 subjects, 72 and six individuals had the +5134G/G and +5134G/A genotype respectively. Allelic frequencies were 96% (+5134G) and 4% (+5135A). The frequency of each polymorphism was also determined in the CEPH reference population. In 111 individuals studied, no polymorphism was detected at positions +3810 and +5134 and all the subjects were +3810 G/G and +5134 G/G. However out of 110 subjects, 51, 48 and 11 individuals presented the +2109A/A and +2109A/G and +2109G/G genotype respectively. Allelic frequencies were 68% (+2109A) and 32% (+2109G) ( Table 2) .
The three new polymorphisms identified in the present study were located in the intronic and 3′UTR regions which are involved in transcriptional regulation. Although none of these new polymorphisms are located in a sequence that was previously demonstrated to be involved in gene regulation. This analysis has been performed on a SUDANESE population living in a region where Schistosoma mansoni infection is endemic. Lethality in Schistosoma mansoni infections is the consequence of portal hypertension caused by hepatic periportal fibrosis. Development of hepatic periportal fibrosis is controlled Figure 4 Restriction analysis of 10a/b PCR products by AciI. The +2109 transition creates a novel AciI restriction site. The search for restriction sites was conducted using the program (http:// www.firstmarket.com/cutter). 5 l of PCR product from subjects 27 and 33 were digested by the restriction enzyme AciI (New England Biolabs, Beverly, MA, USA) under the conditions described by the manufacturer. Digested products were separated on a 2% agarose gel at 100 V.
by a major locus on human chromosome 6 in q22-q23, closely linked to the gene coding for the ␣ chain of the IFN-␥ receptor. 7, 8 This localization is consistent with the strongly antifibrogenic property of IFN-␥. We are currently investigating the importance of the three novel polymorphisms described here in the immune response and in the development of fibrosis.
